Administration of interleukin-1 receptor antagonist ameliorates renal ischemia-reperfusion injury

Transplant International

Volumn 21, Issue 6, 2008, Pages 572-580

  Rusai, Krisztina ^a,b   Huang, Hai ^a   Sayed, Nora ^a   Strobl, Matthias ^a   Roos, Marcel ^a   Schmaderer, Christoph ^a   Heemann, Uwe ^a   Lutz, Jens ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Apoptosis; Inflammation; Interleukin 1 receptor antagonist; Renal ischemia reperfusion; Treatment

Indexed keywords

CELL ADHESION MOLECULE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; HISTOPATHOLOGY; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MALE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL ARTERY; RENAL PROTECTION; REPERFUSION; REPERFUSION INJURY; TISSUE INJURY;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BCL-2-ASSOCIATED X PROTEIN; CHEMOKINE CCL2; DNA PRIMERS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; KIDNEY; LEUKOCYTES; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; REPERFUSION INJURY; RNA, MESSENGER;

EID: 42949169489     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00651.x     Document Type: Article

References (36)

1. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int 2004 66 : 480.
2. Allan SM, Tyrrell PJ, Rothwell NJ. Interleukin-1 and neuronal injury. Nat Rev Immunol 2005 5 : 629.
3. Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 1991 266 : 10331.
4. Suzuki K, Murtuza B, Smolenski RT, et al. Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 2001 104 : I308.
5. Yang GY, Schielke GP, Gong C, et al. Expression of tumor necrosis factor-alpha and intercellular adhesion molecule-1 after focal cerebral ischemia in interleukin-1beta converting enzyme deficient mice. J Cereb Blood Flow Metab 1999 19 : 1109.
6. Haq M, Norman J, Saba SR, Ramirez G, Rabb H. Role of IL-1 in renal ischemic reperfusion injury. J Am Soc Nephrol 1998 9 : 614.
7. Rabb H, O'Meara YM, Maderna P, Coleman P, Brady HR. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int 1997 51 : 1463.
8. Dunn SL, Young EA, Hall MD, McNulty S. Activation of astrocyte intracellular signaling pathways by interleukin-1 in rat primary striatal cultures. Glia 2002 37 : 31.
9. Heemann U, Szabo A, Hamar P, et al. Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury. possible connection to an interleukin-6-dependent pathway. Am J Pathol 2000 156 : 287.
10. Jung SI, Chang GJ, Corbascio M, et al. Expression of intercellular adhesion molecule-1 in the cortex of preserved rat kidneys. J Surg Res 2001 100 : 69.
11. Sung FL, Zhu TY, Au-Yeung KK, Siow YL, O K. Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB. Kidney Int 2002 62 : 1160.
12. Han J, Sabbatini P, Perez D, Rao L, Modha D, White E. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev 1996 10 : 461.
13. Sato N, Hotta K, Waguri S, et al. Neuronal differentiation of PC12 cells as a result of prevention of cell death by bcl-2. J Neurobiol 1994 25 : 1227.
14. Furuichi K, Wada T, Iwata Y, et al. Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury. J Crit Care Med 2006 34 : 2447.
15. Okusa MD. The inflammatory cascade in acute ischemic renal failure. Nephron 2002 90 : 133.
16. Jo SK, Sung SA, Cho WY, Go KJ, Kim HK. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant 2006 21 : 1231.
17. Mahr S, Neumayer N, Gerhard M, Classen M, Prinz C. IL-1beta-induced apoptosis in rat gastric enterochromaffin-like cells is mediated by iNOS, NF-kappaB, and Bax protein. Gastroenterology 2000 118 : 515.
18. Mitchell MD, Laird RE, Brown RD, Long CS. IL-1beta stimulates rat cardiac fibroblast migration via MAP kinase pathways. Am J Physiol Heart Circ Physiol 2007 292 : 1139.
19. Chizzonite R, Truitt T, Kilian PL, et al. Two high-affinity interleukin 1 receptors represent separate gene products. Proc Natl Acad Sci U S A 1989 86 : 8029.
20. Horuk R, Huang JJ, Covington M, Newton RC. A biochemical and kinetic analysis of the interleukin-1 receptor. Evidence for differences in molecular properties of IL-1 receptors. J Biol Chem 1987 262 : 16275.
21. Dripps DJ, Verderber E, Ng RK, Thompson RC, Eisenberg SP. Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils. J Biol Chem 1991 266 : 20311.
22. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991 77 : 1627. Review.
23. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998 16 : 27. Review.
24. Wang X, Barone FC, Aiyar NV, Feuerstein GZ. Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke 1997 28 : 155.
25. Gershenwald JE, Fong YM, Fahey TJ III., et al. Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci U S A 1990 87 : 4966.
26. Yang GY, Mao Y, Zhou LF, et al. Attenuation of temporary focal cerebral ischemic injury in the mouse following transfection with interleukin-1 receptor antagonist. Brain Res Mol Brain Res 1999 72 : 129.
27. Hu X, Nesic-Taylor O, Qiu J, et al. Activation of nuclear factor-kappaB signaling pathway by interleukin-1 after hypoxia/ischemia in neonatal rat hippocampus and cortex. J Neurochem 2005 93 : 26.
28. Pinteaux E, Rothwell NJ, Boutin H. Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia. Glia 2006 53 : 551.
29. Emsley HC, Smith CJ, Georgiou RF, et al. A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatr 2005 76 : 1366.
30. Harada H, Wakabayashi G, Takayanagi A, et al. Transfer of the interleukin-1 receptor antagonist gene into rat liver abrogates hepatic ischemia-reperfusion injury. Transplantation 2002 74 : 1434.
31. Kelly KJ, Williams WW Jr., Colvin RB, Bonventre JV. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci U S A 1994 91 : 812.
32. Rabb H, O'Meara YM, Maderna P, Coleman P, Brady HR. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int 1997 51 : 1463.
33. Dragun D, Lukitsch I, Tullius SG, et al. Inhibition of intercellular adhesion molecule-1 with antisense deoxynucleotides prolongs renal isograft survival in the rat. Kidney Int 1998 54 : 2113.
34. Kelly KJ, Williams WW Jr., Colvin RB, et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996 97 : 1056.
35. Furuichi K, Wada T, Iwata Y, et al. Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. J Am Soc Nephrol 2003 14 : 1066.
36. Hengartner MO. The biochemistry of apoptosis. Nature 2000 407 : 770.